Manila Times Business
Celularity Releases CEO Letter to Shareholders
FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a longevity-focused regenerative and cellular medicine company pioneering placental-derived cellular therapies, today announced that it has posted a Letter to Shareholders from Robert J. Hariri, M.D., Ph.D., Celularity's Founder, Chairman, and Chief Executive Officer, to the Investor Relations section of its website. The letter is also included below. Dear Fellow Shareholders, I
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Israel, Lebanon agree to conditional ceasefire
2h ago
Quantinuum Announces Pricing of Upsized Initial Public Offering
2h ago
Origin Energy and Landis+Gyr bring large-scale smart gas technology to Australian homes and businesses
2h ago
Compal and Datasection Advance AI Infrastructure for the Production Era
2h ago